Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors

• Keller J. Toral,

  Roles Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Pharmaceutical Sciences and Markey Cancer Center, College of Pharmacy, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Mark A. Wuenschel,

  Roles Data curation

  Affiliation Department of Pharmaceutical Sciences and Markey Cancer Center, College of Pharmacy, University of Kentucky, Lexington, Kentucky, United States of America

  ⨯
• Esther P. Black

  Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: penni.black@uky.edu

  Affiliation Department of Pharmaceutical Sciences and Markey Cancer Center, College of Pharmacy, University of Kentucky, Lexington, Kentucky, United States of America

  https://orcid.org/0000-0003-2350-7536

  ⨯